NOV 24, 2020 8:00 AM PST

Young Inventor Creates Award-winning At-home Cancer Diagnostic

WRITTEN BY: Tara Fernandes

Getting a breast cancer diagnosis often means having to endure multiple tests, including some painful and invasive procedures. Detection of malignancy involves one or more tests such as physical examinations, blood tests, mammograms, ultrasounds, MRI scans and tissue biopsies. Inspired by her own mother’s experience with breast cancer, 23-year-old Judit Giró Benet asked the question: what if women could quickly and easily monitor for breast cancer from the comfort of their homes?

In response, Giró Benet created the Blue Box — an AI-powered medical device that analyzes urine in search of specific cancer markers. The results are then wirelessly transmitted to the user’s smartphone via a special app. This potentially life-saving innovation has been awarded the international James Dyson Award 2020, with Giró Benet pocketing a £30,000 cash prize.

The user experience is simple and seamless. Users insert a supplied collection vial containing a urine sample into the Blue Box. Within around 30 seconds, a series of sensors begins reacting with any metabolites in the sample that indicate of the presence of a possible malignancy. The data is then securely sent to the cloud where the algorithm is run to process the data. Upon reaching a diagnosis, the user receives an alert on their phone. All this without having to enter a doctor’s clinic.

According to Giró Benet, the Blue Box doesn’t just work in theory. Thanks to a powerful AI-based diagnostic algorithm, early validation tests set the device’s classification rate at above 95 percent.

“The Blue Box has the potential to make cancer screening a part of daily life. It can help to change the way society fights breast cancer to ensure that more women can avoid an advanced diagnosis,” said Giró Benet who plans to use the prize to fund further development and patent filing with the view of eventually testing the device in clinical trials.

 

 

Sources: The James Dyson Award, iNews.

About the Author
PhD
Interested in health technology and innovation.
You May Also Like
SEP 27, 2022
Clinical & Molecular DX
New Research Elucidates the Mechanism of Skin Cancer Metastasis to the Brain and Points to Groundbreaking Treatment
SEP 27, 2022
New Research Elucidates the Mechanism of Skin Cancer Metastasis to the Brain and Points to Groundbreaking Treatment
In advanced stages of skin cancer, patients develop brain metastases about 90% of the time. Though this is one of the mo ...
OCT 24, 2022
Neuroscience
Why is the Risk of Alzheimer's Higher in Women?
OCT 24, 2022
Why is the Risk of Alzheimer's Higher in Women?
Women tend to get Alzheimer's disease at a significantly higher rate than men; about two-thirds of people with the neuro ...
OCT 24, 2022
Clinical & Molecular DX
A Promising Biomarker for Osteoarthritis Has Been Found
OCT 24, 2022
A Promising Biomarker for Osteoarthritis Has Been Found
Osteoarthritis, the most common form of arthritis, is difficult to diagnose early. Osteoarthritis affects over 32 millio ...
NOV 02, 2022
Health & Medicine
[White Paper] Optimizing Sequencing Costs in Metagenomics. How to Reduce Costs of Pathogen Detection with PaRTI-Seq™
NOV 02, 2022
[White Paper] Optimizing Sequencing Costs in Metagenomics. How to Reduce Costs of Pathogen Detection with PaRTI-Seq™
Optimizing sequencing costs in metagenomics: How to reduce costs of pathogen detection in with PaRTI-Seq™ Pathogen ...
DEC 06, 2022
Cardiology
Wearable Activity Trackers Can Determine Health Metrics
DEC 06, 2022
Wearable Activity Trackers Can Determine Health Metrics
Your smartwatch could help measure your physical and cardiovascular health.
DEC 07, 2022
Drug Discovery & Development
"Study May Proceed" for Major Depressive Disorder Drug
DEC 07, 2022
"Study May Proceed" for Major Depressive Disorder Drug
Vistagen is a clinical-stage pharma company developing drugs for central nervous system disorders (CNS disorders) such a ...
Loading Comments...